Published on 24 Feb 2025 on Benzinga
Robert F. Kennedy Jr.‘s appointment as U.S. Secretary of Health and Human Services has sparked concerns over funding for the National Institutes of Health. Analysts warn that potential cuts to this funding could lead to increased “uncertainty” in the healthcare sector, potentially impacting healthcare stocks.
What Happened: The NIH grants are “very important” sources of funding for a lot of labs out there, said Kyle Mikson, managing director and senior research analyst in conversation with Michael Graham, senior managing director and head of U.S. equity research internet analyst at Canaccord Genuity.